Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M John Albert

Showing results (1-10 of 84) with videos related to

Pageof 9
Sort By:
The Indian Journal of Medical Research|March 29, 2006
Cholera: time for actionM John Albert
The Indian Journal of Medical Research|March 19, 2011
Cross-reactivity of outer membrane proteins of Campylobacter species with cholera toxinM John Albert
The Indian Journal of Medical Research|March 14, 2013
In vitro susceptibility of Campylobacter jejuni from Kuwait to tigecycline & other antimicrobial agentsM John Albert
Vaccine|December 12, 2012
Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from KuwaitEiman Mokaddas, M John Albert
Expert Review of Vaccines|June 9, 2016
Serotype distribution and penicillin-non-susceptibility of Streptococcus pneumoniae causing invasive diseases in Kuwait: A 10-year study of impact of pneumococcal conjugate vaccinesEiman Mokaddas, M John Albert
Emerging Infectious Diseases|November 7, 2009
Hybrid El Tor Vibrio cholerae O1, KuwaitRajinder M Joshi, M John Albert
Clinical and Vaccine Immunology : CVI|March 21, 2008
Major outer membrane proteins from many Campylobacter species cross-react with cholera toxinM John Albert, Shilpa Haridas, Ben Adler
Human Vaccines & Immunotherapeutics|August 26, 2021
The 13-valent pneumococcal conjugate vaccine (PCV13) does not appear to provide much protection on combined invasive disease due to the six PCV13 non-PCV7 serotypes 1, 3, 5, 6A, 7F, and 19A in Kuwait during 2010-2019Eiman Mokaddas, Shabeera Syed, M John Albert
Clinical and Vaccine Immunology : CVI|September 24, 2010
Recombinant PorA, the major outer membrane protein of Campylobacter jejuni, provides heterologous protection in an adult mouse intestinal colonization modelAnjum Islam, Raj Raghupathy, M John Albert
International Journal of Medical Microbiology : IJMM|March 15, 2003
Lack of polymorphism in a Vibrio cholerae O139-specific DNA region encoding the somatic antigen in strains isolated during 1993-1998Susanna Falklind-Jerkérus, M John Albert, Andrej Weintraub
Pageof 9

Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
The Indian Journal of Medical Research|March 29, 2006
Cholera: time for actionM John Albert
The Indian Journal of Medical Research|March 19, 2011
Cross-reactivity of outer membrane proteins of Campylobacter species with cholera toxinM John Albert
The Indian Journal of Medical Research|March 14, 2013
In vitro susceptibility of Campylobacter jejuni from Kuwait to tigecycline & other antimicrobial agentsM John Albert
Vaccine|December 12, 2012
Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from KuwaitEiman Mokaddas, M John Albert
Expert Review of Vaccines|June 9, 2016
Serotype distribution and penicillin-non-susceptibility of Streptococcus pneumoniae causing invasive diseases in Kuwait: A 10-year study of impact of pneumococcal conjugate vaccinesEiman Mokaddas, M John Albert
Emerging Infectious Diseases|November 7, 2009
Hybrid El Tor Vibrio cholerae O1, KuwaitRajinder M Joshi, M John Albert
Clinical and Vaccine Immunology : CVI|March 21, 2008
Major outer membrane proteins from many Campylobacter species cross-react with cholera toxinM John Albert, Shilpa Haridas, Ben Adler
Human Vaccines & Immunotherapeutics|August 26, 2021
The 13-valent pneumococcal conjugate vaccine (PCV13) does not appear to provide much protection on combined invasive disease due to the six PCV13 non-PCV7 serotypes 1, 3, 5, 6A, 7F, and 19A in Kuwait during 2010-2019Eiman Mokaddas, Shabeera Syed, M John Albert
Clinical and Vaccine Immunology : CVI|September 24, 2010
Recombinant PorA, the major outer membrane protein of Campylobacter jejuni, provides heterologous protection in an adult mouse intestinal colonization modelAnjum Islam, Raj Raghupathy, M John Albert
International Journal of Medical Microbiology : IJMM|March 15, 2003
Lack of polymorphism in a Vibrio cholerae O139-specific DNA region encoding the somatic antigen in strains isolated during 1993-1998Susanna Falklind-Jerkérus, M John Albert, Andrej Weintraub
Pageof 9